Liangyong Xia

2PUBLICATIONS
32CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 01, 2026
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

|Jun 19, 2024
Topical JAK inhibition ameliorates EGFR inhibitor-induced rash in rodents and humans.

Qing You, Leying Chen, Shuaihu Li

Pageof 1

Frequent Collaborators

1 joint publications

Qing You

1 joint publications

Leying Chen

1 joint publications

Shuaihu Li

1 joint publications

Meng Tian